It will be interesting to see when the data is bac
Post# of 148181
(Total Views: 500)
Posted On: 09/28/2020 4:35:52 PM
It will be interesting to see when the data is back from CD12, if there are any anecdotal improvements in any other co-morbidities for the participants. Might be another path for identifying unknown indications. (although it seems the list is quite complete).
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼